Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - Change over time

European Journal of Clinical Pharmacology

Volumn 52, Issue 4, 1997, Pages 249-254

  Wandell P E ^a,b   Brorsson, B ^c   Aberg H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Swed Cncl Technol Assess H ^*

^c Swedish Council on Technology Assessment in Health Care   (Sweden)

Author keywords

Antidiabetic drugs; Cardiovascular agnets; Diabetes mellitus; Drug utilisation; Lipid lowering drugs; Primary health care; Sweden

Indexed keywords

ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; DICOUMAROL; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GASTROINTESTINAL AGENT; GLYCERYL TRINITRATE; INSULIN; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PSYCHOTROPIC AGENT; SULFONYLUREA; THIAZIDE DIURETIC AGENT; TRANQUILIZER;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR AGENTS; COMMUNITY HEALTH CENTERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIURETICS; DRUG UTILIZATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PRESCRIPTIONS, DRUG; SWEDEN;

EID: 0030845512     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050285     Document Type: Article

References (34)

1. Molinatti G, Porta M (1990) Diabetes mellitus in Europe: a problem at all ages in all countries. A model for prevention and self care. A meeting organized by WHO and IDF Europe, 10-12 October, 1989, Saint Vincent (Aosta), Italy. G Ital Diabetol 10 [Suppl]: 1-140
2. Alberti K, Gries F (1988) Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabet Med 5: 275-281
3. Anonymous (1990) Treatment of non-insulin-dependent diabetes mellitus. Medical Products Agency, Uppsala, Sweden
4. Haaijer-Ruskamp F (1990) Drug utilization studies in the Netherlands. Pharm Weekbl Sci 12: 91-96
5. Anonymous (1980) Diagnosis-prescription investigation (in Swedish with English summary) Sven Farm Tidskr 84: 313-337
6. Rendell M, Lassek W, Ross D, Smith C, Kernek S, Williams J, Brown M, Willingmyre L, Yamamoto L (1983) A pharmaceutical profile of diabetic patients. J Chron Dis 36: 193-202
7. Isacson D, Stålhammar J (1987) Prescription drug use among diabetics - a population study. J Chron Dis 7: 651-660
8. Gram J, Damsgaard E (1989) Drug consumption in elderly diabetics. Diabetes Res Clin Pract 7: 293-298
9. Van den Brink G, Schwartzenberg R, Hoeve L, Porsius A (1993) The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment. Pharm World Sci 15: 128-131
10. Glauber H, Brown J (1992) Use of health maintenance organization data bases to study pharmacy resource usage in diabetes mellitus. Diabetes Care 15: 870-876
11. Anonymous (1994) Health care data for 1994 for the County of Stockholm. (in Swedish) Stockholms läns landsting, Region-plane- och trafikkontoret, Stockholm
12. Davis P, Gribben B (1995) Rational prescribing and interpractitioner variation. Int J Technol Assess Health Care 11: 428-442
13. Greenfield S, Nelson E, Zubkoff M, Manning W, Rogers W, Kravitz R, Keller A, Tarlov A, Ware J (1992) Variations in resource utilization among medical specialities and systems of care. Results from the Medical Outcomes Study. JAMA 267: 1624-1630
14. Webb S, Lloyd M (1994) Prescribing and referral in general practice: a study of patient's expectations and doctor's actions. Br J Gen Pract 44: 165-169
15. Nordenstam I, Wennberg M, Burman K (1996) Swedish pharmaceutical drug statistics 95. (in Swedish) Apoteksbolaget, Stockholm
16. Groop P, Klaukka T, Reunanen A, Bergman U, Borch-Johnsen K, Damsgaard E, Hreidarsson A, Midthjell K, Stålhammar J, Östman J (1991) Antidiabetic drugs in the Nordic countries. Reasons for variation in their use. (in Swedish with English summary) Folkpensionsanstaltens, Helsingfors, Finland, vol ML: 105
17. Pugh J, Wagner M, Sawyer J, Ramirez G, Tuley M, Friedberg S (1992) Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. Diabetes Care 15: 953-959
18. Scheen A, Castillo M, Lefèbvre P (1993) Combination of oral antidiabetic drugs and insulin in the reatment of non-insulin-dependent diabetes. Acta Clin Belg 48: 259-268
19. United Kingdom Prospective Diabetes Study Group (1995) United Kingdom prospective diabetes study (UKPDS). 13. relative ellicacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310: 83-88
20. Grant P (1996) The effects of high- and medium-dose metformin therapy on cardiovascular risk actors in patients with type II diabetes. Diabetes Care 19: 64-66
21. Wändell P, Brorsson B, Åberg H (1996) Drug use in patients with diabetes. Diabetes Care 19: 992-994
22. Anonymous (1993) Treatment of hypertension in diabetes. Diabetes Care 16: 1394-1401
23. Kendall M, Lynch K, Hjalmarsson Å, Kjekshus J (1995) Beta-blockers and sudden cardiac death. Ann Intern Med 123: 358-367
24. Kjekshus J, Gilpin E, Cali G, Blackey A, Henning H, Ross Jr J (1990) Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 11: 43-50
25. Carella M, Gossain V, Rovner D (1994) Early diabetic nephropathy. Arch Intern Med 154: 625-630
26. Mogensen C (1992) Angiotensin converting enzyme inhibitors and diabetic nephropathy (editorial). BMJ 304: 327-328
27. Remuzzi G, Ruggenenti P (1993) Slowing the progression of diabetic nephropathy (editorial). N Engl J Med 329: 1496-1497
28. Bakris G, Barnhill B, Sadler R (1992) Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 41: 912-919
29. Kannel W, McGee D (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038
30. Rubin R, Peyrot M (1992) Psychosocial problems and interventions in diabetes. Diabetes Care 15: 1640-1657
31. Gavard J, Lustman P, Clouse R (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16: 1167-1178
32. Strandberg K, Beerman B, Lönnerholm G (eds) (1989) Treatment of hyperlipidemia. National Board of Health and Welfare Drug Information Committee, Uppsala, Sweden
33. Sempos C, Cleeman J, Carroll M, Johnson C, Bachorik P, Gordon D, Burt V, Briefel R, Brown C, Lippel K, Rifkind B (1993) Prevalence of high blood cholesterol among US adults. JAMA 269: 3009-3014
34. Johnson C, Rifkind B, Sempos C, Carroll M, Bachorik P, Briefel R, Gordon D, Burt V, Brown C, Lippel K, Cleeman J (1993) Declining serum total cholesterol levels among US adults. JAMA 269: 3002-3008